Clinical trial
Immunogenicity and Safety Study of Topical Recombinant Thrombin in Surgical…
NCT00491608 · ZymoGenetics, Industry · Completed
Key facts
| NCT number | NCT00491608 |
|---|---|
| Title | Immunogenicity and Safety Study of Topical Recombinant Thrombin in Surgical Hemostasis |
| Official title | A Phase 3b, Open-Label, Single-Group Immunogenicity and Safety Study of Topical Recombinant Thrombin (rThrombin) in Surgical Hemostasis |
| Lead sponsor | ZymoGenetics, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Spinal Surgery, Vascular Surgery |
| Intervention type | Biological |
| Interventions | rThrombin |
| Enrollment | 234 |
| Start date | Jun 1, 2007 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Jun 26, 2007 |
| Last update posted | Jan 13, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: